US equities
|
NVDA
$153.59
▼-1.63%
MU
$693.91
▼-3.49%
AMD
$488.24
▼-3.18%
SPCX
$140.80
▲+2.50%
SNDK
$785.93
▼-2.86%
MSFT
$501.71
▼-3.14%
AAPL
$350.43
▼-0.67%
TSM
$358.90
▼-3.89%
NVDA
$153.59
▼-1.63%
MU
$693.91
▼-3.49%
AMD
$488.24
▼-3.18%
SPCX
$140.80
▲+2.50%
SNDK
$785.93
▼-2.86%
MSFT
$501.71
▼-3.14%
AAPL
$350.43
▼-0.67%
TSM
$358.90
▼-3.89%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about NASDAQ:MXCT
Recent news which mentions NASDAQ:MXCT
MXCT Stock Earnings: MaxCyte Beats EPS, Beats Revenue for Q2 2024
August 06, 2024
Tickers
MXCT
Tags
NASDAQ:MXCT
MXCT
Market News
From
InvestorPlace
MXCT Stock Earnings: MaxCyte Beats EPS, Beats Revenue for Q1 2024
May 07, 2024
Tickers
MXCT
Tags
NASDAQ:MXCT
Earnings Reports
MXCT
From
InvestorPlace
Down Over 30% in 2021, is MaxCyte Still a Buy?
January 04, 2022
Tags
NASDAQ:MXCT
NYSE:CO
NYSE:A
From
StockNews.com